Urapidil, but not dihydropyridine calcium channel inhibitors, preserves the hypoxic pulmonary vasoconstriction: an experimental study in pig arteries

Claire Bopp, Cyril Auger, Alexandre Mebazaa, Girish P. Joshi, Valérie B. Schini-Kerth, Pierre Diemunsch

Research output: Contribution to journalArticle

Abstract

Hypoxic pulmonary vasoconstriction (HPV) is a protective mechanism maintaining blood oxygenation by redirecting blood flow from poorly ventilated to well-ventilated areas in the lung. Such a beneficial effect is blunted by antihypertensive treatment with dihydropyridine calcium channel inhibitors. The aim of the present study was to evaluate the effect of urapidil, an antihypertensive agent acting as an α1 adrenergic antagonist and a partial 5-HT1A agonist, on HPV in porcine proximal and distal pulmonary artery rings, and to characterize underlying mechanisms. Rings from proximal and distal porcine pulmonary artery were suspended in organ chambers and aerated with a 95% O2 + 5% CO2 gas mixture. HPV was induced by changing the gas to a 95% N2 + 5% CO2 mixture following a low level of pre-contraction with U46619. Hypoxia induced a contractile response in both proximal and distal pulmonary artery rings. This effect is observed in the presence of a functional endothelium and is inhibited by a soluble guanylyl cyclase inhibitor (ODQ), a NO scavenger (carboxy-PTIO), and by catalase in proximal pulmonary artery rings. The endothelium-dependent HPV is prevented by nicardipine and clevidipine but remained unaffected by urapidil in both proximal and distal pulmonary artery rings. These findings indicate that urapidil, in contrast to nicardipine and clevidipine, preserves the hypoxia-triggered vasoconstriction in isolated pulmonary arteries. They further indicate the involvement of the NO-guanylyl cyclase pathway and H2O2 in HPV. Further research is warranted to determine the potential clinical relevance of the preserved hypoxia-induced pulmonary vasoconstriction by urapidil.

Original languageEnglish (US)
Pages (from-to)527-534
Number of pages8
JournalFundamental and Clinical Pharmacology
Volume33
Issue number5
DOIs
StatePublished - Oct 1 2019

Fingerprint

Calcium Channels
Vasoconstriction
Swine
Pulmonary Artery
Arteries
Lung
Nicardipine
Antihypertensive Agents
Endothelium
Gases
Serotonin 5-HT1 Receptor Agonists
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
Adrenergic Antagonists
Guanylate Cyclase
urapidil
1,4-dihydropyridine
Catalase
Research
Hypoxia

Keywords

  • antihypertensive drug
  • endothelium
  • hypoxic vasoconstriction
  • urapidil
  • vascular reactivity

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

Urapidil, but not dihydropyridine calcium channel inhibitors, preserves the hypoxic pulmonary vasoconstriction : an experimental study in pig arteries. / Bopp, Claire; Auger, Cyril; Mebazaa, Alexandre; Joshi, Girish P.; Schini-Kerth, Valérie B.; Diemunsch, Pierre.

In: Fundamental and Clinical Pharmacology, Vol. 33, No. 5, 01.10.2019, p. 527-534.

Research output: Contribution to journalArticle

Bopp, Claire ; Auger, Cyril ; Mebazaa, Alexandre ; Joshi, Girish P. ; Schini-Kerth, Valérie B. ; Diemunsch, Pierre. / Urapidil, but not dihydropyridine calcium channel inhibitors, preserves the hypoxic pulmonary vasoconstriction : an experimental study in pig arteries. In: Fundamental and Clinical Pharmacology. 2019 ; Vol. 33, No. 5. pp. 527-534.
@article{c9806840d78e418fa3d63ee545f00fbe,
title = "Urapidil, but not dihydropyridine calcium channel inhibitors, preserves the hypoxic pulmonary vasoconstriction: an experimental study in pig arteries",
abstract = "Hypoxic pulmonary vasoconstriction (HPV) is a protective mechanism maintaining blood oxygenation by redirecting blood flow from poorly ventilated to well-ventilated areas in the lung. Such a beneficial effect is blunted by antihypertensive treatment with dihydropyridine calcium channel inhibitors. The aim of the present study was to evaluate the effect of urapidil, an antihypertensive agent acting as an α1 adrenergic antagonist and a partial 5-HT1A agonist, on HPV in porcine proximal and distal pulmonary artery rings, and to characterize underlying mechanisms. Rings from proximal and distal porcine pulmonary artery were suspended in organ chambers and aerated with a 95{\%} O2 + 5{\%} CO2 gas mixture. HPV was induced by changing the gas to a 95{\%} N2 + 5{\%} CO2 mixture following a low level of pre-contraction with U46619. Hypoxia induced a contractile response in both proximal and distal pulmonary artery rings. This effect is observed in the presence of a functional endothelium and is inhibited by a soluble guanylyl cyclase inhibitor (ODQ), a NO scavenger (carboxy-PTIO), and by catalase in proximal pulmonary artery rings. The endothelium-dependent HPV is prevented by nicardipine and clevidipine but remained unaffected by urapidil in both proximal and distal pulmonary artery rings. These findings indicate that urapidil, in contrast to nicardipine and clevidipine, preserves the hypoxia-triggered vasoconstriction in isolated pulmonary arteries. They further indicate the involvement of the NO-guanylyl cyclase pathway and H2O2 in HPV. Further research is warranted to determine the potential clinical relevance of the preserved hypoxia-induced pulmonary vasoconstriction by urapidil.",
keywords = "antihypertensive drug, endothelium, hypoxic vasoconstriction, urapidil, vascular reactivity",
author = "Claire Bopp and Cyril Auger and Alexandre Mebazaa and Joshi, {Girish P.} and Schini-Kerth, {Val{\'e}rie B.} and Pierre Diemunsch",
year = "2019",
month = "10",
day = "1",
doi = "10.1111/fcp.12457",
language = "English (US)",
volume = "33",
pages = "527--534",
journal = "Fundamental and Clinical Pharmacology",
issn = "0767-3981",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Urapidil, but not dihydropyridine calcium channel inhibitors, preserves the hypoxic pulmonary vasoconstriction

T2 - an experimental study in pig arteries

AU - Bopp, Claire

AU - Auger, Cyril

AU - Mebazaa, Alexandre

AU - Joshi, Girish P.

AU - Schini-Kerth, Valérie B.

AU - Diemunsch, Pierre

PY - 2019/10/1

Y1 - 2019/10/1

N2 - Hypoxic pulmonary vasoconstriction (HPV) is a protective mechanism maintaining blood oxygenation by redirecting blood flow from poorly ventilated to well-ventilated areas in the lung. Such a beneficial effect is blunted by antihypertensive treatment with dihydropyridine calcium channel inhibitors. The aim of the present study was to evaluate the effect of urapidil, an antihypertensive agent acting as an α1 adrenergic antagonist and a partial 5-HT1A agonist, on HPV in porcine proximal and distal pulmonary artery rings, and to characterize underlying mechanisms. Rings from proximal and distal porcine pulmonary artery were suspended in organ chambers and aerated with a 95% O2 + 5% CO2 gas mixture. HPV was induced by changing the gas to a 95% N2 + 5% CO2 mixture following a low level of pre-contraction with U46619. Hypoxia induced a contractile response in both proximal and distal pulmonary artery rings. This effect is observed in the presence of a functional endothelium and is inhibited by a soluble guanylyl cyclase inhibitor (ODQ), a NO scavenger (carboxy-PTIO), and by catalase in proximal pulmonary artery rings. The endothelium-dependent HPV is prevented by nicardipine and clevidipine but remained unaffected by urapidil in both proximal and distal pulmonary artery rings. These findings indicate that urapidil, in contrast to nicardipine and clevidipine, preserves the hypoxia-triggered vasoconstriction in isolated pulmonary arteries. They further indicate the involvement of the NO-guanylyl cyclase pathway and H2O2 in HPV. Further research is warranted to determine the potential clinical relevance of the preserved hypoxia-induced pulmonary vasoconstriction by urapidil.

AB - Hypoxic pulmonary vasoconstriction (HPV) is a protective mechanism maintaining blood oxygenation by redirecting blood flow from poorly ventilated to well-ventilated areas in the lung. Such a beneficial effect is blunted by antihypertensive treatment with dihydropyridine calcium channel inhibitors. The aim of the present study was to evaluate the effect of urapidil, an antihypertensive agent acting as an α1 adrenergic antagonist and a partial 5-HT1A agonist, on HPV in porcine proximal and distal pulmonary artery rings, and to characterize underlying mechanisms. Rings from proximal and distal porcine pulmonary artery were suspended in organ chambers and aerated with a 95% O2 + 5% CO2 gas mixture. HPV was induced by changing the gas to a 95% N2 + 5% CO2 mixture following a low level of pre-contraction with U46619. Hypoxia induced a contractile response in both proximal and distal pulmonary artery rings. This effect is observed in the presence of a functional endothelium and is inhibited by a soluble guanylyl cyclase inhibitor (ODQ), a NO scavenger (carboxy-PTIO), and by catalase in proximal pulmonary artery rings. The endothelium-dependent HPV is prevented by nicardipine and clevidipine but remained unaffected by urapidil in both proximal and distal pulmonary artery rings. These findings indicate that urapidil, in contrast to nicardipine and clevidipine, preserves the hypoxia-triggered vasoconstriction in isolated pulmonary arteries. They further indicate the involvement of the NO-guanylyl cyclase pathway and H2O2 in HPV. Further research is warranted to determine the potential clinical relevance of the preserved hypoxia-induced pulmonary vasoconstriction by urapidil.

KW - antihypertensive drug

KW - endothelium

KW - hypoxic vasoconstriction

KW - urapidil

KW - vascular reactivity

UR - http://www.scopus.com/inward/record.url?scp=85071610280&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071610280&partnerID=8YFLogxK

U2 - 10.1111/fcp.12457

DO - 10.1111/fcp.12457

M3 - Article

C2 - 30811659

AN - SCOPUS:85071610280

VL - 33

SP - 527

EP - 534

JO - Fundamental and Clinical Pharmacology

JF - Fundamental and Clinical Pharmacology

SN - 0767-3981

IS - 5

ER -